Staff Members - Benha University
CHA2DS2-VASc-HS score for prediction of adverse inhospital outcomes in patients with non-ST segment elevation myocardial infarction
• 2021
Publication Information
Authors
M.K.Mahmoud, H.M.Kabil, H.H.Ebed and A.M.Sabry
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
For a treatment choice the early identification of non-ST myocardial infarction segment patients
(NSTEMI) with poor in-hospital results is essential. The CHA2DS2-VASc-HS and CHA2DS2-VASc
score was recently reported as a predictor of severity and poor outcomes in individuals with stable
coronary artery disease (CAD) and acute coronary syndrome. Our research aimed at evaluating the
precision of the CHA2DS2-VASc-HS score, which predicts poor outcomes in hospitals in NSTEMI
patients. 120 NSTEMI patients have been enrolled. The score for CHA2DS2-VASc-HS has been
computed. The participants of the research were split into two groups. Group I and Group II score 4. Patients with CHA2DS2-VASc-HS >4
were found to have higher unfavourable outcomes in the hospital than the CHA2DS2-VASc-HS score
(NSTEMI) with poor in-hospital results is essential. The CHA2DS2-VASc-HS and CHA2DS2-VASc
score was recently reported as a predictor of severity and poor outcomes in individuals with stable
coronary artery disease (CAD) and acute coronary syndrome. Our research aimed at evaluating the
precision of the CHA2DS2-VASc-HS score, which predicts poor outcomes in hospitals in NSTEMI
patients. 120 NSTEMI patients have been enrolled. The score for CHA2DS2-VASc-HS has been
computed. The participants of the research were split into two groups. Group I and Group II score 4. Patients with CHA2DS2-VASc-HS >4
were found to have higher unfavourable outcomes in the hospital than the CHA2DS2-VASc-HS score